# Effects of Interleukin-1 Receptor Antagonism on Hyperandrogenemia in Women With Polycystic Ovary Syndrome

> **NCT03578497** · PHASE2 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 18 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** IL-1 receptor antagonist Anakinra

## Key facts

- **NCT ID:** NCT03578497
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-31
- **Primary completion:** 2020-07-30
- **Final completion:** 2020-07-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03578497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03578497, "Effects of Interleukin-1 Receptor Antagonism on Hyperandrogenemia in Women With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03578497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*